Shares of AdvanSix Inc (NYSE:ASIX) have received an average broker rating score of 1.00 (Strong Buy) from the one brokers that provide coverage for the company, Zacks Investment Research reports. One equities research analyst has rated the stock with a strong buy rating.
Analysts have set a 1 year consensus price target of $40.00 for the company, according to Zacks. Zacks has also given AdvanSix an industry rank of 232 out of 255 based on the ratings given to related companies.
ASIX has been the subject of several recent analyst reports. Zacks Investment Research raised AdvanSix from a “hold” rating to a “buy” rating and set a $42.00 price target for the company in a report on Tuesday, April 24th. ValuEngine cut AdvanSix from a “buy” rating to a “hold” rating in a report on Friday, June 1st.
Shares of ASIX traded down $1.34 during mid-day trading on Tuesday, hitting $34.00. The company’s stock had a trading volume of 209,738 shares, compared to its average volume of 196,188. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.31 and a quick ratio of 0.78. The stock has a market capitalization of $1.07 billion, a P/E ratio of 13.75 and a beta of 1.47. AdvanSix has a 1-year low of $29.55 and a 1-year high of $46.51.
AdvanSix (NYSE:ASIX) last posted its quarterly earnings results on Friday, August 3rd. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.87 by $0.04. The business had revenue of $400.46 million during the quarter, compared to analysts’ expectations of $391.10 million. AdvanSix had a return on equity of 22.35% and a net margin of 8.93%. The company’s quarterly revenue was up 10.8% compared to the same quarter last year. During the same period last year, the firm earned $0.83 EPS. research analysts anticipate that AdvanSix will post 2.53 EPS for the current year.
In other news, Director Michael Marberry acquired 1,437 shares of AdvanSix stock in a transaction that occurred on Tuesday, August 7th. The stock was purchased at an average cost of $34.79 per share, with a total value of $49,993.23. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders bought a total of 2,740 shares of company stock valued at $100,134 over the last three months. Insiders own 0.22% of the company’s stock.
A number of hedge funds have recently modified their holdings of ASIX. Point72 Asia Hong Kong Ltd increased its position in AdvanSix by 483.3% during the first quarter. Point72 Asia Hong Kong Ltd now owns 4,200 shares of the company’s stock worth $146,000 after buying an additional 3,480 shares in the last quarter. Envestnet Asset Management Inc. increased its position in AdvanSix by 607.4% during the first quarter. Envestnet Asset Management Inc. now owns 4,230 shares of the company’s stock worth $147,000 after buying an additional 3,632 shares in the last quarter. Meeder Asset Management Inc. increased its position in AdvanSix by 148.9% during the second quarter. Meeder Asset Management Inc. now owns 4,142 shares of the company’s stock worth $152,000 after buying an additional 2,478 shares in the last quarter. Victory Capital Management Inc. increased its position in AdvanSix by 97,980.0% during the first quarter. Victory Capital Management Inc. now owns 4,904 shares of the company’s stock worth $171,000 after buying an additional 4,899 shares in the last quarter. Finally, SG Americas Securities LLC purchased a new position in AdvanSix during the first quarter worth $173,000. 75.75% of the stock is owned by hedge funds and other institutional investors.
AdvanSix Company Profile
AdvanSix Inc manufactures and sells polymer resins in the United States. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce engineered plastics, fibers, filaments, and films. The company also provides caprolactam, ammonium sulfate fertilizers, and acetone, as well as other intermediate chemicals, including phenol, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, cyclohexanol, acetaldehyde oxime, 2-pentanone oxime, sulfuric acid, ammonia, and carbon dioxide.
Recommended Story: Should I follow buy, hold and sell recommendations?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for AdvanSix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdvanSix and related companies with MarketBeat.com's FREE daily email newsletter.